Bayer has filed for approval in the US for elinzanetant as a non-hormonal treatment for menopausal symptoms such as hot flushes, with a rival therapy from Astellas in its sights. The FDA ...

David Edwards has spent over a decade reporting on social justice, human rights and politics for Raw Story. He also writes Crooks and Liars. He has a background in enterprise resource planning and ...